Related Experiment Videos
Cardiac transplantation in children
J R Zuberbuhler1, F J Fricker, B P Griffith
1University of Pittsburgh School of Medicine, Pennsylvania.
Cardiology Clinics
|May 1, 1989
Summary
Pediatric heart transplantation offers a life-changing treatment for severe cardiomyopathy, but faces challenges like congenital heart disease and donor organ shortages. Despite risks and long-term effects of immunosuppression, most children achieve good quality of life post-transplant.
Area of Science:
- Pediatric Cardiology
- Transplant Surgery
- Immunology
Background:
- Heart transplantation is an increasingly accepted treatment for children with end-stage cardiomyopathy.
- Congenital heart disease and elevated pulmonary vascular resistance significantly increase transplantation risks.
- Specialized procedures like heterotopic or heart-lung transplantation are options for specific patient groups.
Purpose of the Study:
- To review the current status and challenges of heart transplantation in pediatric patients.
- To highlight the management of immunosuppression and rejection in pediatric heart recipients.
- To discuss long-term outcomes, complications, and future considerations in pediatric heart transplantation.
Main Methods:
- Review of current clinical practices and outcomes in pediatric heart transplantation.
- Analysis of immunosuppressive regimens including cyclosporine, prednisone, azathioprine, and anti-thymocyte globulin (ATG).
- Evaluation of complications such as infection, rejection, coronary artery disease, and lymphoproliferative disease.
Main Results:
- Chronic immunosuppression is essential, with cyclosporine and prednisone as primary agents.
- Infection remains a significant postoperative problem, alongside long-term drug effects and rejection.
- Common long-term complications include hypertension and decreased renal function; coronary artery disease and lymphoproliferative disease are leading causes of death.
Conclusions:
- Pediatric heart transplantation can enable children to return to age-appropriate activities.
- Donor heart shortage is a growing concern impacting selection criteria.
- Careful management of immunosuppression and vigilant monitoring for complications are crucial for long-term success.